The effect of Panchnnimbadi Churna and an etiopathological study on urticaria (sheetpitta)

An Etiopathological Study of Urticaria (Sheetpitta) and Therapeutic trial of Panchnimbadi Churna - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085758

Enrollment

Registered

2025-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -The sign and symptoms of Urticaria (Sheetpitta) based on both ayurvedic as well as modern view.

Exclusion criteria

Exclusion criteria: -Patients below 12 years and above 60 years. -Immunocompromised patients example HIV. -Patients is unwillings. -Patients with complicated associated symptoms example severly ill liver cirrhosis adenocarcinoma.

Design outcomes

Primary

Measure	Time frame
Sign and symptoms will be assessed before and after treatment. i.e- Kandu, Mandalakar, Utsedna, Toda, Daha, Sotha etcTimepoint: Total 30 Patients Duration- 60 Days	—

Secondary

Measure	Time frame
CBC & LFT test will be done in patients before & after treatmentTimepoint: Total- 30 Patients Duration- 60 DAYS	—

Countries

India

Contacts

Public ContactDr Amarendra kumar singh

Government of Ayurvedic college and hospital, Patna

singh.amrendra70@yahoo.co.in9931230820

Outcome results